1Department of Sport and Leisure Studies, Yonsei University, Seoul, korea.
2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, korea.
3Department of Exercise and Sports Science, Jeju National University, Jeju, Korea.
Copyright © 2011 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Values are presented as mean±standard deviation.
BMI, body mass index; WC, waist circumference; HC, hip circumference; WHR, waist-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein-3; IMT, intima-media thickness.
aLog-transformed value comparison, bIMT was measured in 92 students.
Values are presented as mean±standard deviation. 1st, BMI<19.9; 2nd, 20≤BMI≤22.3; 3rd, BMI >22.3.
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein-3.
aP<0.05 vs. 1st, bP<0.05 vs. 2nd, cLog-transformed value comparison.
Model 1, unadjusted; Model 2, adjusted for BMI.
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein-3; IMT, intima-media thickness.
aP<0.05.
Model 1, unadjusted; Model 2, adjusted for BMI.
IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance.
aP<0.05.
Model 1, unadjusted; Model 2, adjusted for BMI.
IMT, intima-media thickness; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein-3.
aP<0.05.
Values are presented as mean±standard deviation. BMI, body mass index; WC, waist circumference; HC, hip circumference; WHR, waist-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein-3; IMT, intima-media thickness. aLog-transformed value comparison, bIMT was measured in 92 students.
Values are presented as mean±standard deviation. 1st, BMI<19.9; 2nd, 20≤BMI≤22.3; 3rd, BMI >22.3. BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein-3. a
Model 1, unadjusted; Model 2, adjusted for BMI. BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein-3; IMT, intima-media thickness. a
Model 1, unadjusted; Model 2, adjusted for BMI. IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance. a
Model 1, unadjusted; Model 2, adjusted for BMI. IMT, intima-media thickness; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostasis model assessment-insulin resistance; IGF-1, insulin-like growth factor 1; IGFBP-3, insulin-like growth factor binding protein-3. a